Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    11259643 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Multicenter Efficacy Study of Recombinant Human Erythropoietin in Acute Ischemic Stroke
Conditions: Infarction, Middle Cerebral Artery;   Middle Cerebral Artery Stroke;   Stroke, Acute
Interventions: Drug: recombinant human erythropoietin alfa;   Drug: 0.9% NaCl

Study has passed its completion date and status has not been verified in more than two years.